Journal
BRITISH JOURNAL OF ANAESTHESIA
Volume 120, Issue 5, Pages 914-927Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.bja.2018.01.023
Keywords
anticoagulants; cardiopulmonary bypass; haemostasis; heparin
Categories
Funding
- Department of Anaesthesiology
- Department of Cardio-thoracic Surgery of VU University Medical Center, Amsterdam, The Netherlands
Ask authors/readers for more resources
Neutralisation of systemic anticoagulation with heparin in cardiac surgery with cardiopulmonary bypass requires protamine administration. If adequately dosed, protamine neutralises heparin and reduces the risk of postoperative bleeding. However, as its anticoagulant properties are particularly exerted in the absence of heparin, overdosing of protamine may contribute to bleeding and increased transfusion requirements. This narrative review describes the mechanisms underlying the anticoagulant properties and side-effects of protamine, and the impact of protamine dosing on the activated clotting time and point-of-care viscoelastic test results, and explains the distinct protamine dosing strategies in relation to haemostatic activation and postoperative bleeding. The available evidence suggests that protamine dosing should not exceed a protamine-to-heparin ratio of 1:1. In particular, protamine-to-heparin dosing ratios > 1 are associated with more postoperative 12 h blood loss. The optimal protamine-to-heparin ratio in cardiac surgery has, however, not yet been elaborated, and may vary between 0.6 and 1.0 based on the initial heparin dose.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available